von Willebrand Disease clinical trials
12 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
- A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
- Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
- Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
- Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- A Study Assessing HMB-002 in Participants With Von Willebrand Disease
- Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
- The Severe Von Willebrand Disease (sVWD) Patient Registry
- Von Willebrand Factor in Pregnancy (VIP) Study
- ATHNdataset Registry
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “von Willebrand Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.